Colin Bennion;Premji Meghani;Anthony Ronald Cook;Mark Ebden;Roger Victor Bonnert
发明人:
Mark Ebden,Premji Meghani,Colin Bennion,Anthony Ronald Cook,Roger Victor Bonnert
申请号：
US12508934
公开号：
US08106063B2
申请日:
2009.07.24
申请国别(地区):
US
年份:
2012
代理人:
摘要：
A compound of formula (I), pharmaceutically acceptable salt, solvate or in vivo hydrolysable ester thereof for the treatment of asthma, allergic rhinitis, COPD, inflammatory bowel disease, irritable bowel syndrome, osteoarthritis, osteoporosis, rheumatoid arthritis, psoriasis or cancer.
